At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top London based Managing Partner operating in the Health Care space. If you think a Managing Partner is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Stuart McAlpine
Managing Partner of Cinven
Stuart leads the Business Services and Industrials sector teams. He is also a member of the Healthcare sector team and the UK and Ireland regional team. He has been involved in a number of transactions, including Amadeus, AMCo, CPA Global, Fitness First, Foseco, Medpace, Phadia, Sebia and Unique Pub Company. Stuart was previously with the Royal Bank of Scotland in its Leveraged Finance Group and before that at Ernst & Young in Boston and London. Stuart has a BAcc in Accountancy from Glasgow University. He joined Cinven in 1996.
Follow Stuart McAlpine:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Pal Erik Sjatil
Global Managing Partner and CEO of Lightrock
Pal Erik Sjatil is the Global Managing Partner and CEO at Lightrock, a global private equity partnership that seeks to achieve financial as well as societal and environmental returns. Lightrock invests in sustainable businesses built by purpose-driven entrepreneurs committed to innovation for systemic change at scale. The company has one of the largest impact-focused growth portfolios in Europe, Latin America and India. More recently, Lightrock has also started building out a portfolio of investments across Sub-Saharan Africa. It invests in companies that pursue scalable and technology-driven business models around the themes people, planet and productivity/tech for good. Specific investment sectors within these themes include education, healthcare, access to finance, mobility, transportation, renewables and circular-economy transition. Lightrock investments demonstrably contribute to the United Nation’s Sustainable Development Goals. Lightrock’s portfolio currently encompasses more than 70 high-growth companies, including Infarm, one of the world’s fastest growing urban farming networks with more than 1200 farms installed; PharmEasy, one of the largest omni-channel healthcare platforms in India; DrConsulta, one of the largest healthcare chains in Latin America; and M-Kopa, a global pioneer for pay-as-you-go solar energy services for off-grid customers in rural East Africa. In 2019, CMR Surgical, a developer of surgical robots that will broaden access to keyhole surgery, was the first of Lightrock’s portfolio companies to become a unicorn – followed by several others, such as Lilium, the sustainable aviation company. As an active owner, Lightrock supports its portfolio companies from a board position in their dynamic growth and expansion phase. Prior to joining Lightrock, Pal Erik Sjatil was a Senior Partner at McKinsey & Company, a member of the firm’s Shareholders Council, and the Managing Partner of McKinsey’s offices in Europe. Before assuming that role, he led McKinsey’s office in Norway, was part of the leadership of the Scandinavian offices, led the office complex in Eastern Europe, and was the Managing Partner of McKinsey’s offices in EEMA (Eastern Europe, Russia/CIS, Turkey, the Middle East, and Africa). Pal Erik also held leadership roles in the firm’s Telecommunications, High Tech, and Strategy & Corporate Finance practices. At McKinsey, he served clients in the telecom, high tech, financial services, and oil and gas industries and focused on corporate strategy, operations, and organizational transformations.
Follow Pal Erik Sjatil:
About Lightrock: Lightrock is a global private equity platform that backs purpose-driven entrepreneurs tackling the world’s biggest challenges.
Nick Moakes
Managing Partner of Investments and Chief Investment Officer of Wellcome Trust
Nick is directly responsible for Wellcome’s global equity, FX and derivatives exposure, as well as playing a key role in broader investment strategy and management of the Investment Team. He is a member of our Investment Committee. Nick joined Wellcome in 2007 from BlackRock Investment Management where he was Head of the Asia Pacific investment team and co-head of Emerging Markets. He has 27 years’ professional experience in Asia, and 22 years’ experience in global equity markets. He graduated in Modern History and Economics from Balliol College, Oxford, and is a CFA charter holder. Before joining BlackRock in 1997, Nick lived in Hong Kong for nine years. He is a Chinese speaker. He started his career in the Diplomatic Service. Nick is Chair of the Imperial College London Endowment Fund and a Non-Executive Director of the Foreign and Colonial Investment Trust. He’s also a Board Member of the UK Investor Forum, which aims to align the interests of listed companies and long-term shareholders.
Follow Nick Moakes:
About Wellcome Trust: Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health.
Houman Ashrafian
Managing Partner & Founder of SV Health Investors
Houman Ashrafian is the Managing Partner at SV Health Investors.
Follow Houman Ashrafian:
About Catamaran Bio, Cellinta, Enara Bio, Karus Therapeutics, Sitryx Therapeutics, SV Health Investors, Zarodex Therapeutics: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Kate Bingham
Managing Partner of SV Health Investors
Kate Bingham joined SVLS in 1991. Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Alantos, Auxilium, ESBATech, EUSA, Hexagen, Kinetix, KuDOS, Leukosite, Mednova, Micromet, PowderMed, RespiVert and current investments including Autifony, Bicycle, Convergence, Oncoethix and TopiVert.
Follow Kate Bingham:
About SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Sam Gray
Managing Partner of Apposite Capital
Follow Sam Gray:
About Apposite Capital, OrthoD Group: Apposite Capital is a London-based investment firm focused on healthcare services and life sciences companies.
David Davenport-Firth
Managing Partner, Brain Sciences Centre of Ogilvy Health
David Davenport-Firth leads health behaviour strategy and intervention, driving and supporting Ogilvy CommonHealth Worldwide’s position as the health behaviour specialists of Ogilvy. He is a self-confessed ‘quantified selfer’ and is passionate about health data visualisation and wearable technology. He is particularly interested in clinical decision making behaviour and how the psychosocial dimensions of health and illness can be better managed through visualisation and digital engagement. As such, he relishes collaborations with Central Saint Martins, Imperial College London, the University of Oxford Health Experiences Research Group, Warwick Business School the University of Westminster and is an active member of the #ogilvychange community. After working in innovation management and marketing, including two years in the United States, David returned to England to join Coley Porter Bell, becoming Chairman in 2001. He later moved into Ogilvy’s health network and after establishing a consulting offer and re-engineering the digital health practice in London, he switched his focus to behavioural medicine.
Follow David Davenport-Firth:
About Ogilvy Health: Ogilvy Health is a marketing and advertising agency that specializes in the health care industry.
